Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Assets (2020 - 2025)

Biofrontera (BFRI) has 6 years of Current Assets data on record, last reported at $14.4 million in Q3 2025.

  • For Q3 2025, Current Assets fell 14.87% year-over-year to $14.4 million; the TTM value through Sep 2025 reached $14.4 million, down 14.87%, while the annual FY2024 figure was $20.7 million, 10.29% down from the prior year.
  • Current Assets reached $14.4 million in Q3 2025 per BFRI's latest filing, down from $18.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $48.5 million in Q3 2022 and bottomed at $10.1 million in Q3 2021.
  • Average Current Assets over 5 years is $28.2 million, with a median of $21.9 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 378.38% in 2022, then crashed 46.51% in 2023.
  • A 5-year view of Current Assets shows it stood at $46.4 million in 2021, then dropped by 7.07% to $43.1 million in 2022, then plummeted by 46.51% to $23.1 million in 2023, then dropped by 10.29% to $20.7 million in 2024, then tumbled by 30.37% to $14.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $14.4 million in Q3 2025, $18.8 million in Q2 2025, and $15.3 million in Q1 2025.